What is the SUBOXONE Film, AUTHORIZED GENERIC OF SUBOXONE® Film, SUBOXONE Tablets, and SUBUTEX Tablets REMS?
The Food and Drug Administration (FDA) has required a Risk Evaluation and Mitigation Strategy (REMS) for SUBOXONE Film, the Authorized Generic of SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. A REMS is a strategy to mitigate known or potential serious risks associated with a drug product and is required by the FDA to ensure that the benefits of a drug outweigh its risks.
The purpose of the SUBOXONE Film, the Authorized Generic of SUBOXONE Film, SUBOXONE Tablet, and SUBUTEX Tablet REMS program is to inform healthcare professionals and patients about the safe use conditions and serious risks, including accidental overdose, misuse, and abuse, associated with buprenorphine-containing transmucosal products indicated for the treatment of opioid dependence.
What products are covered under SUBOXONE Film, AUTHORIZED GENERIC OF SUBOXONE® Film, SUBOXONE Tablets, and SUBUTEX Tablets?
Buprenorphine-containing products are available both as products containing the single active ingredient, buprenorphine, and products that combine buprenorphine with naloxone; both types of products are indicated for the treatment of opioid dependence.
The following products are covered under SUBOXONE Film, AUTHORIZED GENERIC OF SUBOXONE® Film, SUBOXONE Tablets, and SUBUTEX Tablets:
- SUBOXONE® (buprenorphine/naloxone) sublingual film
- Authorized Generic of SUBOXONE® (buprenorphine and naloxone) sublingual film
- SUBOXONE® (buprenorphine hydrochloride/naloxone hydrochloride) sublingual tablet
- SUBUTEX® (buprenorphine hydrochloride) sublingual tablet
The use of buprenorphine-containing products should be part of a comprehensive treatment plan to include counseling and psychosocial support. Treatment must be initiated under the direction of prescribers qualified under the Drug Addiction Treatment Act of 2000.
Where can I obtain additional information?
Please see the Prescribing Information and Medication Guides for all four buprenorphine-containing products.
For more information about SUBOXONE Film, AUTHORIZED GENERIC OF SUBOXONE® Film, SUBOXONE Tablets, and SUBUTEX Tablets, including all program materials and instructions call 1-866-463-4846 or visit www.SuboxoneREMS.com
General information about buprenorphine treatment and the treatment of addiction are available through numerous sources, including but not limited to:
To report SUSPECTED ADVERSE EVENTS, contact: